Literature DB >> 16443776

SGK1 kinase upregulates GLUT1 activity and plasma membrane expression.

Monica Palmada1, Christoph Boehmer, Ahmad Akel, Jeyaganesh Rajamanickam, Sankarganesh Jeyaraj, Konrad Keller, Florian Lang.   

Abstract

Phosphatidylinositol 3-kinase (PI3 kinase) inhibition disrupts the ability of insulin to stimulate GLUT1 and GLUT4 translocation into the cell membrane and thus glucose transport. The effect on GLUT4 but not on GLUT1 is mediated by activation of protein kinase B (PKB). The serum- and glucocorticoid-inducible kinase SGK1, a further kinase downstream of PI3 kinase, regulates several transporters by enhancing their plasma membrane abundance. GLUT1 contains a consensus site ((95)Ser) for phosphorylation by SGK1. Thus, the present study investigated whether GLUT1 is regulated by the kinase. Tracer-flux studies in Xenopus oocytes and HEK-293 cells demonstrated that GLUT1 transport is enhanced by constitutively active (S422D)SGK1. The effect requires the kinase catalytical activity since the inactive mutant (K127N)SGK1 failed to modulate GLUT1. GLUT1 stimulation by (S422D)SGK1 is not due to de novo protein synthesis but rather to an increase of the transporter's abundance in the plasma membrane. Kinetic analysis revealed that SGK1 enhances maximal transport rate without altering GLUT1 substrate affinity. These observations suggest that SGK1 regulates GLUT1 and may contribute to or account for the PI3 kinase-dependent but PKB-independent stimulation of GLUT1 by insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443776     DOI: 10.2337/diabetes.55.02.06.db05-0720

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

Review 1.  Significance of SGK1 in the regulation of neuronal function.

Authors:  Florian Lang; Nathalie Strutz-Seebohm; Guiscard Seebohm; Undine E Lang
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

2.  Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.

Authors:  Chetan V Jawale; Kritika Ramani; De-Dong Li; Bianca M Coleman; Rohan S Oberoi; Saran Kupul; Li Lin; Jigar V Desai; Greg M Delgoffe; Michail S Lionakis; Filitsa H Bender; Alexander J Prokopienko; Thomas D Nolin; Sarah L Gaffen; Partha S Biswas
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 17.956

Review 3.  Renal glucose transporters: novel targets for hyperglycemia management.

Authors:  Amanda Mather; Carol Pollock
Journal:  Nat Rev Nephrol       Date:  2010-03-30       Impact factor: 28.314

4.  Insulin and SGK1 reduce the function of Na+/monocarboxylate transporter 1 (SMCT1/SLC5A8).

Authors:  Adriana López-Barradas; Tania González-Cid; Norma Vázquez; Marisol Gavi-Maza; Adriana Reyes-Camacho; Laura A Velázquez-Villegas; Victoria Ramírez; Kambiz Zandi-Nejad; David B Mount; Nimbe Torres; Armando R Tovar; Michael F Romero; Gerardo Gamba; Consuelo Plata
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

5.  Ras-ling with new therapeutic targets for metastasis.

Authors:  Joshua A Mason; Zachary T Schafer
Journal:  Small GTPases       Date:  2017-05-04

6.  Strong association of serum- and glucocorticoid-regulated kinase 1 with peripheral and adipose tissue inflammation in obesity.

Authors:  M H Schernthaner-Reiter; F Kiefer; M Zeyda; T M Stulnig; A Luger; G Vila
Journal:  Int J Obes (Lond)       Date:  2015-03-26       Impact factor: 5.095

7.  SGK1 dependence of insulin induced hypokalemia.

Authors:  Krishna M Boini; Dirk Graf; Dietmar Kuhl; Dieter Häussinger; Florian Lang
Journal:  Pflugers Arch       Date:  2008-07-30       Impact factor: 3.657

Review 8.  Targeting SGK1 in diabetes.

Authors:  Florian Lang; Agnes Görlach; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

9.  Reversal of tumor immune inhibition using a chimeric cytokine receptor.

Authors:  Ann M Leen; Sujita Sukumaran; Norihiro Watanabe; Somala Mohammed; Jacqueline Keirnan; Ryu Yanagisawa; Usanarat Anurathapan; David Rendon; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Juan F Vera
Journal:  Mol Ther       Date:  2014-03-20       Impact factor: 11.454

Review 10.  The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.

Authors:  Florian Lang; Ferruh Artunc; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.